Drug · DIN 02171228
SYNTHROID
112 MCG TABLET
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 18, 2016; first marketed December 31, 1996.
- Drug Identification Number (DIN)
- 02171228
- Company (DIN owner)
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Levothyroxine sodium H03AA01
- Class
- Human
- Record last updated
- September 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVOTHYROXINE SODIUM | 112 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 30, 2014: NOC 16475New Drug Submission (NDS) · Transfer of drug identification numbers
Other DINs named SYNTHROID
- DIN 02172062 · Marketed
- DIN 02172070 · Marketed
- DIN 02172089 · Marketed
- DIN 02172097 · Marketed
- DIN 02172100 · Marketed
- DIN 02172119 · Marketed
- DIN 02172127 · Marketed
- DIN 02172135 · Marketed
- DIN 02172143 · Marketed
- DIN 02172151 · Marketed
- DIN 02233852 · Marketed